David T. Rubin, MD, the Joseph B. Kirsner Professor of Medicine, Chief, Section of Gastroenterology, Hepatology and Nutrition, and Co-Director, Digestive Diseases Center has been awarded the 2020 Sherman Prize in recognition of his unique and meaningful contributions in the fight to overcome IBD.
Dr. Rubin earned a medical degree with honors at The University of Chicago Pritzker School of Medicine and completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago, where he served as Chief Resident and Chief Fellow. Prior to his current appointments, Dr. Rubin served for 11 years as Director of the Gastroenterology, Hepatology and Nutrition Fellowship Program. He also currently serves as an associate faculty member at the MacLean Center for Clinical Medical Ethics and an associate investigator at the University of Chicago Comprehensive Cancer Center.
Dr. Rubin’s clinical practice is focused on the care of patients with Crohn’s disease and ulcerative colitis. He believes in delivering state of the art care in an environment of compassion and unique access for patients and referring MD’s, and derives great satisfaction working with his patient population. His model for health care delivery must stand up to his test of how he’d want his family to be treated. With these values in mind, he has built an acclaimed IBD center to provide comprehensive care in a highly efficient and compassionate manner to patients.
As an investigator, Dr. Rubin has risen to national and international prominence for his expertise in inflammatory bowel disease, investigational therapies, colon cancer prevention and medical ethics. His current research is in the area of biosensor monitoring of IBD, prevention of progressive complications from uncontrolled inflammation, and a variety of collaborative studies related to the microbiome and causes of IBD and its complications. He is a key opinion leader in the field, and has contributed to many research studies and publications about the disease. Dr. Rubin’s research that demonstrated inflammation as a risk factor for colorectal cancer in IBD patients has made a profound impact on treatment goals and his recent work leading education efforts around COVID-19 and IBD has shaped patient care during these challenging times.
The Sherman Prize was founded in 2016 by the Bruce and Cynthia Sherman Charitable Foundation to honor innovators from a variety of professional disciplines who have dedicated their careers to the fight to overcome IBD and represent “Excellence in Crohn’s and Colitis” in their chosen endeavors. Every year, two $100,000 Sherman Prizes are awarded to IBD visionaries to recognize their exceptional and pioneering contributions that have transformed the care of people with IBD. The Sherman Prize is considered the highest honor in the field of IBD.
Dr. Rubin has dedicated his career to IBD research and patient care and has made exceptional contributions to the field as a clinician, educator, mentor and leader. He is an inspiration to his trainees and to IBD professionals, motivating their own work and research, and a beacon of hope to patients who know that he’ll never stop fighting for them.
For more information about Dr. Rubin’s Prize, click here.